Stiff-man syndrome in a patient with Hodgkin's disease. An unusual paraneoplastic syndrome.

Abstract:

:A case of stiff-man syndrome (SMS), a rare and dramatic CNS disease characterized by continuous muscle activity and painful spasms resembling a chronic form of tetanus, occurring in a patient with Hodgkin's disease (HD) is reported. The patient developed the clinical features of SMS at the same time as the HD relapse. A satisfactory improvement was obtained with diazepam, but the complete recovery from stiffness was achieved only after chemotherapy was started. Cerebellar autoantibodies were found in the serum of the patient. With chemotherapy the patient achieved a second complete remission (CR). Eighteen months later the patient developed a second HD relapse, and at that time no signs of SMS were detected.

journal_name

Haematologica

journal_title

Haematologica

authors

Ferrari P,Federico M,Grimaldi LM,Silingardi V

subject

Has Abstract

pub_date

1990-11-01 00:00:00

pages

570-2

issue

6

eissn

0390-6078

issn

1592-8721

journal_volume

75

pub_type

杂志文章
  • Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.

    abstract:BACKGROUND AND OBJECTIVE:Abnormalities in the expression of cell adhesion molecules (CAM) are thought to influence the patterns of intranodal growth and hematogeneous spread of malignant cells in chronic lymphoproliferative disorders (LPD). Therefore, the characterization of CAM phenotypic profiles of the neoplastic cl...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Lúcio PJ,Faria MT,Pinto AM,da Silva MR,Correia Júnior ME,da Costa RJ,Parreira AB

    更新日期:1998-02-01 00:00:00

  • Effect of interleukin-1beta and glutathione S-transferase genotypes on the development of gastric mucosa-associated lymphoid tissue lymphoma.

    abstract::e tested whether polymorphic variations in glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and interleukin-1 (IL-1beta and IL-1RN) genes confer susceptibility to mucosa-associated lymphoid tissue lymphomas (MALT) in a Chinese population. The rates of GSTM1, GSTP1, IL-1beta and IL-1RN genotypes did not differ bet...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Wu MS,Shun CT,Huang SP,Cheng AL,Chen LT,Lin JT

    更新日期:2004-08-01 00:00:00

  • The natural history of trilinear myelodysplastic syndrome and erythroleukemia.

    abstract::A case of Di Guglielmo's syndrome passed through the three stages of chronic erythromyelosis, erythroleukemia and acute myeloid leukemia (AML). According to the FAB classification the subsequent stages of this syndrome were refractory anemia (RA), RA with excess of blasts (RAEB), AML-M6, AML-M2 and undifferentiated AM...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Michiels JJ,van der Meulen J,Brederoo P

    更新日期:1997-07-01 00:00:00

  • Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts.

    abstract:BACKGROUND:During the final stages of differentiation of mammalian erythroid cells, the chromatin is condensed and enucleated. We previously reported that Rac GTPases and their downstream target, mammalian homolog of Drosophila diaphanous 2 (mDia2), are required for enucleation of in vitro cultured mouse fetal liver er...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2010.029827

    authors: Ji P,Yeh V,Ramirez T,Murata-Hori M,Lodish HF

    更新日期:2010-12-01 00:00:00

  • Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen B*44 allotypes.

    abstract:BACKGROUND:Polymorphic differences between donor and recipient human leukocyte antigen class I molecules can result in graft-versus-host disease due to distinct peptide presentation. As part of the peptide-loading complex, tapasin plays an important role in selecting peptides from the pool of potential ligands. Class I...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2011.046037

    authors: Badrinath S,Saunders P,Huyton T,Aufderbeck S,Hiller O,Blasczyk R,Bade-Doeding C

    更新日期:2012-01-01 00:00:00

  • Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results.

    abstract:BACKGROUND AND OBJECTIVE:Idarubicin (IDA) is relatively immune to the multidrug resistance P-gp mechanism that is frequently expressed in recurrent and refractory hematologic malignancies. Owing to rapid metabolism in vivo, a continuous infusion (CI) of IDA might prolong exposure time to the parent drug rather than its...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章

    doi:

    authors: Bassan R,Chiodini B,Zucchetti M,Lerede T,Cornelli PE,Cortelazzo S,Barbui T

    更新日期:1998-01-01 00:00:00

  • Erythroid marrow activity and functional anemia in patients with the rare interaction of a single functional a-globin and beta-globin gene.

    abstract:BACKGROUND AND OBJECTIVES:The degree of globin chain imbalance and tissue hypoxia are important determinants of clinical severity in thalassemia syndromes. Thus phenotypic expression may be modified by interaction of alpha- and beta-thalassemia defects, level and type of hemoglobin synthesized and oxygen release to the...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Traeger-Synodinos J,Papassotiriou I,Vrettou C,Skarmoutsou C,Stamoulakatou A,Kanavakis E

    更新日期:2001-04-01 00:00:00

  • Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration.

    abstract::In this open label pilot safety study 80 children over 3 months old with deep venous thrombosis were treated with enoxaparin with a target 4 h anti-factor Xa activity between 0.5-0.8 IU/mL. The children were stratified to receive once daily or twice daily doses. The study end-points were post-thrombotic syndrome, re-t...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Schobess R,Düring C,Bidlingmaier C,Heinecke A,Merkel N,Nowak-Göttl U

    更新日期:2006-12-01 00:00:00

  • Resistance to activated protein C as a risk factor of stroke in a thalassemic patient.

    abstract::It is well known that thalassemic patients exhibit an increased frequency of thrombotic events. Most individuals with resistance to activated protein C (APCR) are the result of a point mutation replacing Arg 506 with Gln in the factor V aminoacidic sequence (factor V Leiden). Recently APCR has been shown to account fo...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Giordano P,Sabato V,Schettini F,De Mattia D,Iolascon A

    更新日期:1997-11-01 00:00:00

  • Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.

    abstract:BACKGROUND AND OBJECTIVES:High-dose melphalan with autologous peripheral blood stem cell transplantation (ASCT) is an effective treatment for systemic primary amyloidosis. This procedure is, however, associated with substantial toxicity and mortality, particularly if the heart is involved. Refined selection of patients...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Perfetti V,Siena S,Palladini G,Bregni M,Di Nicola M,Obici L,Magni M,Brunetti L,Gianni AM,Merlini G

    更新日期:2006-12-01 00:00:00

  • Rapamycin is highly effective in murine models of immune-mediated bone marrow failure.

    abstract::Acquired aplastic anemia, the prototypical bone marrow failure disease, is characterized by pancytopenia and marrow hypoplasia. Most aplastic anemia patients respond to immunosuppressive therapy, usually with anti-thymocyte globulin and cyclosporine, but some relapse on cyclosporine withdrawal or require long-term adm...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2017.163675

    authors: Feng X,Lin Z,Sun W,Hollinger MK,Desierto MJ,Keyvanfar K,Malide D,Muranski P,Chen J,Young NS

    更新日期:2017-10-01 00:00:00

  • Migfilin supports hemostasis and thrombosis through regulating platelet αIIbβ3 outside-in signaling.

    abstract::Elucidating the regulation mechanism of integrin αIIbβ3 is key to understand platelet biology and thrombotic diseases. Previous in vitro studies have implicated a role of migfilin in the support of platelet αIIbβ3 activation, however, contribution of migfilin to thrombosis and hemostasis in vivo and a detailed mechani...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2019.232488

    authors: Zhou Y,Hu M,Chen X,Wang S,Li J,Sa L,Li L,Huang J,Cheng H,Hu H

    更新日期:2020-11-01 00:00:00

  • Hb Foggia or alpha 117(GH5)Phe -> Ser: a new alpha 2 globin allele affecting the alpha Hb-AHSP interaction.

    abstract::We report a novel alpha2-globin gene allele with the mutation cod 117 TTC>TCC or alpha 117(GH5)Phe>Ser detected in three carriers with alpha-thalassemia phenotype. The mutated mRNA was present in the reticulocytes in the same amount as the normal one, but no chain or hemoglobin variant were detected. Most likely the a...

    journal_title:Haematologica

    pub_type: 信件

    doi:10.3324/haematol.11789

    authors: Lacerra G,Scarano C,Musollino G,Flagiello A,Pucci P,Carestia C

    更新日期:2008-01-01 00:00:00

  • Pulmonary hypertension in POEMS syndrome.

    abstract::POEMS syndrome is a rare clonal plasma cell disease. Patients with POEMS syndrome are at risk of developing pulmonary hypertension, but the data on its incidence and impact on outcome are limited. We reviewed records of 154 POEMS syndrome patients with complete duplex echocardiography data for estimation of pulmonary ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2012.073031

    authors: Li J,Tian Z,Zheng HY,Zhang W,Duan MH,Liu YT,Cao XX,Zhou DB

    更新日期:2013-03-01 00:00:00

  • A role for activated endothelial cells in red blood cell clearance: implications for vasopathology.

    abstract:BACKGROUND:Phosphatidylserine exposure by red blood cells is acknowledged as a signal that initiates phagocytic removal of the cells from the circulation. Several disorders and conditions are known to induce phosphatidylserine exposure. Removal of phosphatidylserine-exposing red blood cells generally occurs by macropha...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2011.048694

    authors: Fens MH,van Wijk R,Andringa G,van Rooijen KL,Dijstelbloem HM,Rasmussen JT,de Vooght KM,Schiffelers RM,Gaillard CA,van Solinge WW

    更新日期:2012-04-01 00:00:00

  • A genetic score for the prediction of beta-thalassemia severity.

    abstract::Clinical and hematologic characteristics of beta(β)-thalassemia are determined by several factors resulting in a wide spectrum of severity. Phenotype modulators are: HBB mutations, HBA defects and fetal hemoglobin production modulators (HBG2:g.-158C>T polymorphism, HBS1L-MYB intergenic region and the BCL11A). We chara...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究

    doi:10.3324/haematol.2014.113886

    authors: Danjou F,Francavilla M,Anni F,Satta S,Demartis FR,Perseu L,Manca M,Sollaino MC,Manunza L,Mereu E,Marceddu G,Pissard S,Joly P,Thuret I,Origa R,Borg J,Forni GL,Piga A,Lai ME,Badens C,Moi P,Galanello R

    更新日期:2015-04-01 00:00:00

  • The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).

    abstract:BACKGROUND:In a study of childhood acute lymphoblastic leukemia (CoALL 06-97 study), the in vitro sensitivity of the patients' cells to prednisolone, vincristine and asparaginase was introduced as a new additional risk parameter for treatment stratification. In parallel in vivo treatment response was assessed by determ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2010.039735

    authors: Escherich G,Tröger A,Göbel U,Graubner U,Pekrun A,Jorch N,Kaspers G,Zimmermann M,zur Stadt U,Kazemier K,Pieters R,Den Boer ML,Horstmann M,Janka GE,CoALL study group, Hamburg, Germany.

    更新日期:2011-06-01 00:00:00

  • Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.

    abstract:BACKGROUND AND OBJECTIVES:Detection of minimal residual disease (MRD) by multiparameter flow cytometry is an emerging prognostic factor in patients with acute myeloid leukemia (AML). The present analysis aimed at improving the applicability of this approach to more patients with AML. DESIGN AND METHODS:Bone marrow sam...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Kern W,Danhauser-Riedl S,Ratei R,Schnittger S,Schoch C,Kolb HJ,Ludwig WD,Hiddemann W,Haferlach T

    更新日期:2003-06-01 00:00:00

  • Quantification of D-dimer using a new fully automated assay: its application for the diagnosis of deep vein thrombosis.

    abstract:BACKGROUND AND OBJECTIVE:A D-dimer assay can be helpful to rule out thromboembolism provided it is sensitive, reliable, fast and easy to perform. Tests based on the ELISA methodology have a high diagnostic sensitivity, and are therefore adequate for excluding deep venous thrombosis (DVT). The drawbacks are their long a...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Villa P,Ferrando F,Serra J,Faus H,Mira Y,Vayá A,Aznar J

    更新日期:2000-05-01 00:00:00

  • Interferon-alpha 2b is not effective in the treatment of refractory immune thrombocytopenic purpura.

    abstract::About 25-30% of patients with immune thrombocytopenic purpura (ITP) are refractory to corticosteroids, splenectomy and other treatments. It has been suggested that interferon-alpha 2b (IFN-alpha 2b) may be useful in the treatment of chronic refractory ITP patients. We treated 9 chronic refractory ITP patients with IFN...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Vianelli N,Tazzari PL,Baravelli S,Ricci F,Valdrè L,Tura S

    更新日期:1998-08-01 00:00:00

  • Acute nonlymphocytic leukemia in the elderly: results of a retrospective study.

    abstract::Seventy-four patients over 60 years of age with new cases of ANLL diagnosed between January, 1980 and December, 1986 were retrospectively evaluated. Twenty-nine (median age 63, range 60-70) received aggressive induction polychemotherapy: 15 achieved CR (52%), 10 were resistant (34.5%) and 4 died during induction (13.5...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Latagliata R,Sgadari C,Pisani F,Falconi M,Spadea A,Vegna ML,Petti MC

    更新日期:1989-03-01 00:00:00

  • Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.

    abstract::Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a monocentric retrospective analysis of liver disease in a cohort of 191 transfusion-dependent thalassemics, in 126 patients who had undergone liver biopsy (mean age 17.2 years; 58 hepatitis virus C-RNA positive and 68 hepatitis vir...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.12554

    authors: Di Marco V,Capra M,Gagliardotto F,Borsellino Z,Cabibi D,Barbaria F,Ferraro D,Cuccia L,Ruffo GB,Bronte F,Di Stefano R,Almasio PL,Craxì A

    更新日期:2008-08-01 00:00:00

  • Recombinant interferon alpha-2B for acute post-transfusion hepatitis in acute myeloid leukemia.

    abstract::Post-transfusion hepatitis (PTH) is a major problem in patients with acute leukemias requiring blood products during induction or consolidation therapy. In fact, PTH causes delays of chemotherapy with major violations in the timing of protocols. In order to assess the efficacy and safety of a short course of alpha-int...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章

    doi:

    authors: Almasio P,Mirto S,Malleo C,Di Marco V,Caronia F,Craxi A

    更新日期:1991-09-01 00:00:00

  • Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A.

    abstract::Prostacyclin (PGI2) controls platelet activation and thrombosis through a cyclic adenosine monophosphate (cAMP) signaling cascade. However, in patients with cardiovascular diseases this protective mechanism fails for reasons that are unclear. Using both pharmacological and genetic approaches we describe a mechanism by...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2018.213348

    authors: Berger M,Raslan Z,Aburima A,Magwenzi S,Wraith KS,Spurgeon BEJ,Hindle MS,Law R,Febbraio M,Naseem KM

    更新日期:2020-03-01 00:00:00

  • Hemojuvelin (HJV)-associated hemochromatosis: analysis of HJV and HFE mutations and iron overload in three families.

    abstract::Juvenile hemochromatosis is a severe form of hereditary iron overload. It can be caused by mutations in either hepcidin or hemojuvelin genes. In this study we identified the molecular basis of juvenile hemochromatosis in three Australian families and assessed the role of potential modifying genes in individuals carryi...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Wallace DF,Dixon JL,Ramm GA,Anderson GJ,Powell LW,Subramaniam N

    更新日期:2005-02-01 00:00:00

  • Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial.

    abstract:BACKGROUND:There is variability in the outcome of patients with chronic lymphocytic leukemia with apparently the same stage of disease. Identifying genetic variants that influence patients' outcome and response to treatment may provide important insights into the biology of the disease. DESIGN AND METHODS:We investiga...

    journal_title:Haematologica

    pub_type: 杂志文章,随机对照试验

    doi:10.3324/haematol.2011.043471

    authors: Wade R,Di Bernardo MC,Richards S,Rossi D,Crowther-Swanepoel D,Gaidano G,Oscier DG,Catovsky D,Houlston RS

    更新日期:2011-10-01 00:00:00

  • Cytogenetic characterization of acute myeloid leukemia in Shwachman's syndrome. A case report.

    abstract::We report on a case of acute myeloid leukemia in a 17-year old boy affected by Shwachman Diamond syndrome (SDS). Conventional cytogenetics at diagnosis revealed an abnormal clone with complex karyotypic changes including typical myeloid aberrations, such as monosomy 5, tetrasomy of chromosome 8, trisomy 9, and deletio...

    journal_title:Haematologica

    pub_type: 杂志文章,评审

    doi:

    authors: Spirito FR,Crescenzi B,Matteucci C,Martelli MF,Mecucci C

    更新日期:2000-11-01 00:00:00

  • Clinicopathological analysis of malignant lymphoma in Taiwan, defined according to the World Health Organization classification.

    abstract::We report the distribution and clinicopathological characteristics of malignant lymphomas in Taiwan, defined according to the WHO classification. Data including age and gender of the patients, clinical staging and disease courses were collected for 598 cases of malignant lymphomas. The results showed that the epidemio...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Lee MY,Tan TD,Feng AC,Liu MC

    更新日期:2005-12-01 00:00:00

  • Detection of risk groups in myelodysplastic syndromes. A multicenter study.

    abstract:BACKGROUND AND OBJECTIVES:Myelodysplastic syndromes (MDS) comprise a group of heterogeneous hematologic disorders with risk of leukemic evolution (LE). The French-American-British (FAB) co-operative group classifies them into five morphologic entities and the International Prognostic Scoring System (IPSS) proposes four...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Belli C,Acevedo S,Bengio R,Arrossagaray G,Watman N,Rossi N,García J,Flores G,Goldztein S,Larripa I

    更新日期:2002-01-01 00:00:00

  • Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients.

    abstract:BACKGROUND AND OBJECTIVES:To assess the efficacy and the toxic profile of gemcitabine, a novel pyrimidine antimetabolite active against several solid tumors, we carried out a study in heavily pretreated Hodgkin's disease (HD) patients. DESIGN AND METHODS:From May 1997 to January 1999, 14 pretreated patients (10 relaps...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章

    doi:

    authors: Zinzani PL,Bendandi M,Stefoni V,Albertini P,Gherlinzoni F,Tani M,Piccaluga PP,Tura S

    更新日期:2000-09-01 00:00:00